DISTANT RECURRENCES AT MEDIAN OF 5-YEARS AMONG 9.779 POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER TREATED ON THE TEAM TRIAL OF ADJUVANT ENDOCRINE THERAPY